4 November 2015 - NICE has published final draft guidance recommending ciclosporin (Ikervis) manufactured by Santen Pharmaceutical) for treating severe keratitis in adults with dry eye disease which has not improved despite treatment with artificial tears.

For more details, go to: http://www.nice.org.uk/news/press-and-media/nice-gives-green-light-to-dry-eye-disease-treatment-in-final-draft-guidance